
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
EFFECT OF LEKHANA BASTI AND TAB.ATORVASTATIN IN THE MANAGEMENT OF DYSLIPIDEMIA –A COMPARATIVE CLINICAL STUDY
*Pooja B.A, Santoshkumar Bhatted, Meera K.Bhojani
Abstract Dyslipidemia one of the life style disorder due to the today’s faulty life style .Every 1% increase in cholesterol level there is 1-2% increase in the incidence of Coronary Heart Disease. Lipids can be correlated to that of Medo Dhatu. According to the scattered references Dyslipidemia can be correlated to Medo Dosha and subsequently as Medoroga. The treatment principles mainly includes Samshodhana Chikitsa(Bio cleansing),where as in modern statins are first choice of drug. Looking into the limitations in the modern medication clinical trial was carried out in 60 patients having Dyslipidaemia were divided into 2 groups A and B ( 30 patients each). Group A was administered with Lekhana Basti and in Group B Tab.Atorvastatin was advised. The effect of treatment on the complete lipid profile was assessed after the treatment and after the follow up. Total duration of the study was 90 days. Statistical analysis showed highly significant result in the lipid profile. Keywords: Dyslipidemia, Lipid profile, Lekhana Basti, Atorvastatin. [Full Text Article] [Download Certificate] |
